EGFR and non-small cell lung carcinoma: Hence, the aim of the present study is to evaluate the ‘plasma first’ approach using liquid biopsy in advanced stage treatment naïve NSCLC patients for early detection of EGFR mutation and compare it with ‘tissue first’ approach.